Fallypride

DB15167InvestigationalSmall molecule

Fallypride is under investigation in clinical trial NCT02310360 (Striatal and Extra-striatal Dopamine Release in Response to Food in Healthy Humans).

Chemical structure of Fallypride
Mechanism
Curator reviewed
Formula / weight
C20H29FN2O3 · 364.461 g/mol (avg)

Resolves to

Compound
UNIIG9FWZ369GXCAS166173-78-0ChEMBLCHEMBL392158
Structure
InChIKeyOABRYNHZQBZDMG-INIZCTEOSA-NSMILESCOC1=C(OC)C(=CC(CCCF)=C1)C(=O)NC[C@@H]1CCCN1CC=C
Targets
P21917DRD4P35462DRD3P14416DRD2P61169Drd2

What you can answer from here — as of July 08, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
26Drug interactionsStructured to mechanism, not free text
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
12+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Fallypride, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In